Stem Cell Therapy Treatment Improvements in Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment Improvements in Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Could stand with calipers and wal...
By: neurogenbsi
The rest is here:
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Ankle clonus/jerk in both legs has reduced. P...
By: neurogenbsi
More:
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India. - Video
Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy PT assessment: 1) Speech has improved. Now he is abl...
By: neurogenbsi
Read more:
Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma, Mumbai, India. - Video
Stem cell therapy for AVN in India, Experience of patient from Canada
Avascular necrosis also known as osteonecrosis, aseptic necrosis, and ischemic bone necrosis. It is a disease resulting from the temporary or permanent loss ...
By: StemRx BioScience
Read this article:
Stem cell therapy for AVN in India, Experience of patient from Canada - Video
Dr. Lee is one of the first in Texas to use adipose stem cell treatment to care for patients.
Plano, TX (PRWEB) April 03, 2013
Adipose tissue is fat inside the body. Fat is the richest source of adult stem cells in the human body. Stem cells help fight disease or injury by repairing or rejuvenating affected tissue in the body. Medical researchers believe that stem cell treatments have the potential to change the face of human disease.
In the procedure performed by Dr. Lee, fat will be extracted from the body, purified and re-injected into specific areas that need stem cells. Dr. Lee uses an automated machine called the Adivive Lipokit to perform the fat transplantation. The Adivive Lipokit is an all-in-one, FDA-approved device that collects, filters and transfers fat for use in cosmetic and reconstructive surgeries. The Lipokit is able to keep transferred fat cells alive throughout the process.
Procedures that will use adipose stem cell therapy include breast augmentation, facelift surgery, liposuction and fat transfer.
Besides cosmetic purposes, Dr. Lee will also use the Lipokit stem cell therapy for rejuvenation to help relieve chronic pain, whether from aging or due to injuries.
About the company
Advanced Surgical Arts was established in Plano, Texas in 2003. With three board certifications, Dr. Doohi Lee is able to offer his patients a multi-faceted approach to health and well-being. Continuing education is a priority for Dr. Lee, and he regularly attends seminars and conferences to expand his knowledge on cosmetic procedures and anti-aging. Dr. Lee constantly strives to investigate the latest and most minimally invasive procedures in cosmetic and laser vein surgery. His unified approach with artistry and technology provide patients at Advanced Surgical Arts with optimum results. For more information, please visit their website at http://advsurgicalartsdallas.com.
Maggie Gordon Advanced Surgical Arts Dallas 469-666-1075 Email Information
Go here to read the rest:
Dr. Doohi Lee introduces Stem Cell Therapy at Advanced Surgical Arts
ARAD, Israel, April 2, 2013 /PRNewswire/ --
Andain Inc. (ANDN) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its incubator program, today discussed and provided an update on its breakthrough, innovative stem cell therapy for treating and regenerating severely damaged muscle tissue.
Andain's innovative stem cell therapy technology rehabilitates and heals damaged muscle tissue by initiating regenerative myogenic cells (cardiac muscle), as well as striated muscle cells (skeletal muscle) growth in damaged tissue sites such as the myocardium (cardiac muscle) following an myocardial infarction (heart attack), limb pressure ulcers, and degenerative muscular diseases. The short term application is directed towards the treatment of patients with peripheral vascular disease, while the long term application is focused on the healing and regeneration of cardiac muscle following acute myocardial infarction or chronic heart failure.
Employing a patient's own cells (autologic transplantation), the Company's unique technology and process diverts the patient's own cells into specific targeted myogenic cells, which can then be inserted into the damaged tissue and accelerates the healing process. The administered myogenic or skeletal stem cells work as a network, acting in exactly the same way that the cells of skeletal and heart muscle tissue perform, and actually replenish the existing cells, thus strengthening the intended injured site following the transplantation process. This process can be utilized for different clinical pathologies as mentioned above and can also be utilized for patient using different donor as the source of the stem cells.
Our developed technology and protocols results in a promising safe regenerative therapy, without side effects, tissue rejection or the requirement of suppressive immunological treatment or malignant tumor hazard. Our technology also provides a simple, fast and safe treatment, overcoming technological difficulties associated with using other stem cell therapies sources such as embryonic, placenta, or umbilical cord blood cells that require cryogenic storage.
Andain's President and CEO Sam Elimelech, commented, "The field of stem cell therapeutics is in its early stages of growth as companies and researchers continue to uncover the vast potential and promising uses for them in the treatment and prevention of countless tissue injuries and diseases. We are in an excellent position to capitalize on the emergence of this new market. It is our belief that Orcell's cutting-edge technology and process is unique in regard to the fact that it allows for the safe and efficient directing of the patients own cells as into myogenic cells or striated muscle cells, thus eliminating the hazards associated with rejection and malignant tumors. Via our industrial incubator platform and expert scientific team, we look forward to helping Orcell commence their clinical trials later this year and make considerable progress of their technology and process closer to market."
Andain's incubator platform is currently undergoing with its stem cell technology a build-up of GLP (Good Laboratory Practice) production line as a preparation for the FDA approval stage with clinical trials scheduled for Q1 2014 at one of the foremost Heart centers in Israel under the direction of Professor Mickey Scheinowitz, one of Israel's leading scientists who gained vast experience in the understanding and treating of cardiovascular diseases.
ABOUT ANDAIN INC
Established in 2004 as a Nevada corporation with locations in Israel and the US, Andain (OTC: ANDN) commercializes novel technologies in the biotech, medical and life sciences fields, specializing in identifying technical innovations and providing a unique incubator/accelerator development and industrial platform. The company also offers technical know-how and business strategy expertise to commercialize new technologies and deliver shareholder value. For more information, please visit our website at http://www.andaininc.com.
FORWARD LOOKING STATEMENTS
See more here:
By Tina G. Santos Philippine Daily Inquirer
MANILA, PhilippinesStem cell therapy at spa centers and salons? Watch out, government agents are coming.
Health Secretary Enrique Ona says no clinic or hospital in the Philippines can offer stem cell therapy without accreditation from the Department of Health (DOH).
Speaking to reporters last week, Ona noted that while many centers are advertising stem cell therapy treatment, none of them have the approval of the health department.
As of now we have not accredited any clinic or even hospital offering stem cell therapy yet, Ona said.
Admitting that the DOH doesnt have the police power to close down erring health centers, Ona said the department would coordinate with other governmental agencies like the Department of Trade and Industry (DTI) and local governments to prevent spas and salons from offering stem cell treatment.
We will issue a warning for them to stop [doing stem cell therapy]. But if they continue despite warnings from us, thats when we will move to close them down, Ona said.
Stem cell therapy and treatment, which are becoming popular here and abroad, are medical procedures that deal with ailments by replacing malignant cells with healthy cells.
Only medical doctors with the right training can perform stem cell treatment.
Cosmetic purposes
Excerpt from:
Spas, salons warned on stem cell therapy
Bridgewater Veterinary Hospital has been offering stem cell therapy treatment since 2010. We are now proud to announce the addition of Dr. Spencer Silvers to our veterinarians certified to perform this innovative procedure.
Chronic pain can lead to a significant decrease in your pets quality of life over time. Often, this pain can be managed through medications, dietary supplements, and/or physical therapy. However, in cases where these methods are not possible or the pet is unresponsive, stem cell therapy is a highly recommended alternative.
Owners are looking for a different approach to helping ease their pets pain and Vet-Stem Cell therapy is a new answer for some animals.
Vet-Stem Cell therapy is a procedure that uses an animals own stem cells to promote regeneration of new cells in the damaged tissue. It can be used in cases of arthritis in the knee, hip, and elbow. It can also be used in repairing partial ligament tears or to strengthen surgical repair of complete ligament tears.
The technology used in Vet-Stem Cell therapy has been commercially available since 2003. Eighty percent of dogs will have improvement after the Vet-Stem regenerative cells are implanted. Improvement can range from mild to dramatic. After Stem cell therapy, it is common for dogs to be able to either decrease their use of Non Steroidal Anti-Inflammatory drugs or discontinue use completely.
Stem cell therapy in animals has no connection to the controversy sparked by the use of embryonic stem cells as in humans. The therapy uses your own animals natural healing cells, similar to the way human adult stem cells are used in bone marrow transplants.
Murphy, a beautiful four year old black Laborador Retriever, was introduced to Bridgewater Veterinary Hospital about five months ago with torn cruciate ligaments in both knees as well as hip dysplasia.
To manage her chronic pain and to improve her quality of life, BVH performed a surgical repair of the ligament and injected her own isolated stem cells from her fat tissue into all of her painful joints on March 21, 2013. Her recovery was remarkable and you can continue to follow her story on our Facebook page.
For more success stories or to learn more about stem cell therapy, please contact Bridgewater Veterinary Hospital at 908-704-6700 or visit us at bridgewatervet.com and vet-stem.com.
Read the original post:
Murphy’s Story: Stem cell therapy at Bridgewater Veterinary Hospital
Italian health officials are allowing a handful of patients to continue with a controversial stem cell therapy amid protests from scientists that the treatments are unproven and unsafe.
The Stamina Foundation has been administering the therapy at the public hospital Spedali Civili of Brescia to people with a range of degenerative diseases. Their approach is based on mesenchymal stem cells, derived from bone marrow, which can become mature bone and connective tissue.
In 2011 the hospital agreed to host the research and assist with cell extraction and patient treatments, stirring protests from the medical community. "The hospital is not even listed among the 13 Italian authorised stem cell factories," says Michele de Luca, director and gene therapy programme coordinator at the Centre for Regenerative Medicine in Modena. After an inspection in 2012, Italian drug regulator AIFA ordered an immediate halt to Stamina's stem cell treatments at the hospital.
The AIFA report says the Stamina Foundation's treatment did not follow Italy's official path required for clinical approval. So far no scientific publications describing its effectiveness are available.
But the halt sparked protests among patients' families who believed the treatment was working. Some appealed to the courts, and as a result a few patients were allowed to go ahead with the therapy. On 15 March, a group of 13 Italian stem cell researchers published an open letter to the country's Minister of Health, Renato Balduzzi, asking him to shut down all of the Stamina Foundation's treatments at the hospital.
Instead Balduzzi signed a bill last week authorising the foundation to continue treatments in patients who had already begun the regime unless they are experiencing serious side effects.
If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.
Only subscribers may leave comments on this article. Please log in.
Only personal subscribers may leave comments on this article
Subscribe now to comment.
See the rest here:
Italy pushes on with controversial stem cell therapy
MarketResearchReports.biz Publishes Stem Cell Therapy Market in Asia-Pacific to 2018 Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity. Buy the copy of this Report @ http://www.marketresearchreports.biz/analysis-details/stem-cell-therapy-market-in-asia-pacific-to-2018-commercialization-supported-by-favorable-government-policies-strong-pipeline-and-increased-licensing-activity
Albany, NY (PRWEB) March 29, 2013
To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis/155690
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.
GBI Research analysis finds the stem cell therapy market was valued at $545m in 2012, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10% from 2012 to 2018, to attain a value of $972m in 2018. The market is poised for significant growth in the forecast period due to the anticipated launch of JCR Pharmaceuticals JR-031 (2014) in Japan and FCB Pharmicells Cerecellgram (CCG) (2015) in South Korea.
Related Report: Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes
The research is mainly in early stages, with the majority of the molecules being in early stages of development (Phase I/II and Phase II). Phase I/II and Phase II contribute 67% of the pipeline. Stem cell research is dominated by hospitals/universities/institutions, which contribute 63% of the molecules in the pipeline. The dominance of institutional research is attributable to uncertain therapeutic outcomes in stem cell research.The major companies conducting research in India include Reliance Life Sciences and Stempeutics Research Pvt Ltd, among others. The major institutions include PGIMER and AIIMS.
Latest Report: Global SMB Web Analytics Market 2012-2016
Scope
Country analysis of regulatory framework of India, China, South-Korea, Japan and Singapore
See more here:
Stem Cell Therapy Market in Asia-Pacific to 2018 Market Research Report Available at MarketResearchReports.biz
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma After Stem Cell Therapy 1) Ankle dorsiflexion movements are possible now. 2) He is able ...
By: neurogenbsi
More:
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma - Video
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma After Stem Cell Therapy 1) Eye contact improved (not very marked). 2) Increased interaction with sis...
By: neurogenbsi
Follow this link:
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma - Video
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma Mumbai India
By: neurogenbsi
Go here to see the original:
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma Mumbai India - Video
Stem Cell Therapy for Pets -- Midnight Before After
Amazing before and after footage of Midnight, a dog who received stem cell therapy for her arthritic joints. We discovered a side benefit of better skin and ...
By: NewmanVets
Excerpt from:
Stem Cell Therapy for Pets -- Midnight Before
Stem Cell Therapy for Pets - Bandit Before After
Amazing before and after footage of Bandit, a 5 year old dog who received stem cell therapy for his arthritis and hip dysplasia. For more information about s...
By: NewmanVets
See the original post here:
Stem Cell Therapy for Pets - Bandit Before
By: Azer N. Parrocha, Philippine News Agency March 28, 2013 3:16 AM
InterAksyon.com The online news portal of TV5
MANILA, Philippines - Although guidelines for stem cell therapy in the country have already been released, the Department of Health (DOH) on Wednesday reminded the public that hospitals performing the treatment are as of the moment, not accredited.
Health Secretary Enrique Ona, in a press conference, explained that for a hospital or clinic to be considered accredited, a years worth of tests and studies have to be done to prove that the procedure is indeed safe and effective.
I hope the general public understands that these stem cells, although called innovative (form of treatment) is not standard and should not be advertised as though it is already an accepted form of treatment, Ona said.
Ona explained that the DOH still continues to look on the capacity of the treatment and will make sure that the stem cells used for procedure are accepted as protocol.
Stem cells like those coming from embryos or animals which are restricted will also be looked into by the DOH to see if there are any hospitals or clinics that do not abide by the administrative order.
If the protocol is accepted, report of results should be evaluated, he said. They are evaluated about a year to see if their claim is effective [and if it is] it will be validated.
At present, there are no hospitals or clinics completely accredited for the stem cell therapy yet. Given that, certain processes must be followed before doctors are allowed to use the treatment.
I cannot see a so-called clinic yet certifying that there is a process that is very effective, Ona explained. We have to see the type of stem cell, the type of claim they have.
Read more here:
Hospitals performing stem cell therapy are yet to be accredited – DOH
Stem Cell Therapy for Pets - Kye Before After
Amazing before and after footage of Kye, an 11 year old lab who received stem cell therapy for his arthritis. For more information about stem cell therapy fo...
By: NewmanVets
Excerpt from:
Stem Cell Therapy for Pets - Kye Before
Stem Cell Therapy for Pets - Guiness Before After
Amazing before and after footage of Guiness, an 11 year old dog who received stem cell therapy for his arthritis and got an unexpected side benefit. For more...
By: NewmanVets
See the original post:
Stem Cell Therapy for Pets - Laleigh Before After
Amazing before and after footage of Laleigh, a 10 year old dog who received stem cell therapy for arthritis. For more information about stem cell therapy for...
By: NewmanVets
More:
Stem Cell Therapy for Pets - Sammy Before After
Amazing before and after footage of Sammy, a yellow lab who received stem cell therapy for his arthritic joints. For more information about stem cell therapy...
By: NewmanVets
See the original post: